Ellen Rohde

Corporate Officer/Principal presso VERVE THERAPEUTICS, INC.

57 anni

Health Technology

Consumer Services

Profilo

Ellen Rohde is currently the VP-Preclinical Pharmacology & Toxicology at Verve Therapeutics, Inc. She previously worked as an Associate Director at Biogen, Inc., Director-Analytical Chemistry & DMPK at Cerulean Pharma, Inc., and Senior Director-Pharmacokinetics at Intellia Therapeutics,.
Inc. Rohde holds a doctorate degree from the University of Cincinnati (Ohio) and a graduate degree from Universität Leipzig.

Posizioni attive di Ellen Rohde

Società	Posizione	Inizio
VERVE THERAPEUTICS, INC.	Corporate Officer/Principal	01/10/2019

Tutte le posizioni attive di Ellen Rohde

Precedenti posizioni note di Ellen Rohde

Società	Posizione	Fine
Cerulean Pharma, Inc. Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA.	Corporate Officer/Principal	-
BIOGEN INC.	Corporate Officer/Principal	-
INTELLIA THERAPEUTICS, INC.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Ellen Rohde

Formazione di Ellen Rohde

University of Cincinnati (Ohio)	Doctorate Degree
Universität Leipzig	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Ellen Rohde

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	3
VERVE THERAPEUTICS, INC.	Health Technology
INTELLIA THERAPEUTICS, INC.	Health Technology
BIOGEN INC.	Health Technology

Aziende private	1
Cerulean Pharma, Inc. Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA.	Health Technology